- Gainers: MultiPlan (NYSE:MPLN) +17%, Trinity Biotech (NASDAQ:TRIB) +15%, Acutus Medical (NASDAQ:AFIB) +11%, Novan (NASDAQ:NOVN) +8%, Salarius Pharmaceuticals (NASDAQ:SLRX) +7%.
- Losers: Evoke Pharma (NASDAQ:EVOK) -17%, Curis (NASDAQ:CRIS) -16%, UroGen Pharma (NASDAQ:URGN) -16%, Eargo (NASDAQ:EAR) -13%, Haemonetics (NYSE:HAE) -13%.